Preliminary experiments suggest conolidine may inhibit distinct ion channels, lowering neuronal excitability and limiting discomfort indicators. This system is particularly appropriate in neuropathic pain, in which irregular signaling brings about persistent discomfort. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pat